Contact Us
Prothrombin Complex Concentrate Global Market Report 2025
Global Prothrombin Complex Concentrate Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Prothrombin Complex Concentrate Global Market Report 2025

By Product (3-Factor Prothrombin Complex Concentrates, 4-Factor Prothrombin Complex Concentrates, Other Products), By Indication (Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B), Trauma, Life-Threatening Coagulopathy With Acute Bleeding, Warfarin-Associated Acute, Life-Threatening Bleeding, Non-Warfarin Anticoagulant Reversal With Acute Bleeding), By Route Of Administration (Intravenous, Subcutaneous, Intramuscular), By End-Use (Hospital And Ambulatory Surgical Centers, Specialty Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Prothrombin Complex Concentrate Market Overview

• Prothrombin Complex Concentrate market size has reached to $1.29 billion in 2024

• Expected to grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%

• Growth Driver: Rising Prevalence Of Bleeding Disorders Driving The Growth Of The Market Due To Increasing Genetic Mutations and Inherited Conditions

• Market Trend: Development Of Innovative Formulations In The Market

North America was the largest region in 2024.

What Is Covered Under Prothrombin Complex Concentrate Market?

Prothrombin complex concentrate (PCC) is a medication containing clotting factors used to treat or prevent bleeding in patients with coagulation disorders. It is administered intravenously to rapidly restore clotting factor levels in conditions such as hemophilia, warfarin reversal, and severe bleeding episodes.

The main product types in prothrombin complex concentrate include 3-factor prothrombin complex concentrates (3F-PCC), 4-factor prothrombin complex concentrates (4F-PCC), and other products. 3-factor prothrombin complex concentrates (3F-PCC) are blood products containing clotting factors II, IX, and X, used to manage bleeding without the need for factor VII supplementation. These are indicated for various conditions, including hemorrhagic episodes in factor IX deficiency (hemophilia B), Trauma, life-threatening coagulopathy with acute bleeding, warfarin-associated acute life-threatening bleeding, and non-warfarin anticoagulant reversal in the presence of acute bleeding. Routes of administration are intravenous (IV), subcutaneous, and intramuscular injections, and are used in hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

Prothrombin Complex Concentrate Market Size and growth rate 2025 to 2029: Graph

What Is The Prothrombin Complex Concentrate Market Size 2025 And Growth Rate?

The prothrombin complex concentrate market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in the prevalence of bleeding disorders, increased use in warfarin reversal, growth in awareness of coagulation therapies, expansion of surgical procedures, and increased trauma cases.

What Is The Prothrombin Complex Concentrate Market Growth Forecast?

The prothrombin complex concentrate market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growing demand for rapid coagulation therapies, increasing prevalence of hemophilia and liver diseases, rising adoption in emergency medicine, expanding applications in cardiac surgeries, and increasing healthcare expenditure. Major trends in the forecast period include integration of AI-driven diagnostics, advancements in recombinant coagulation factors, next-generation recombinant pccs, customized dosing algorithms and advancements in blood plasma products.

The forecast of 7.3% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of Prothrombin Complex Concentrate therapies and coagulation testing kits sourced from Austria and Spain, exacerbating treatment costs for bleeding disorders and increasing hematology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Prothrombin Complex Concentrate Market Segmented?

1) By Product: 3-Factor Prothrombin Complex Concentrates, 4-Factor Prothrombin Complex Concentrates, Other Products

2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B), Trauma, Life-Threatening Coagulopathy With Acute Bleeding, Warfarin-Associated Acute, Life-Threatening Bleeding, Non-Warfarin Anticoagulant Reversal With Acute Bleeding

3) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular

4) By End-Use: Hospital And Ambulatory Surgical Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Type: Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC), High-Dose 3-Factor Prothrombin Complex Concentrates (PCC), Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)

2) By Type: Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC), High-Dose 4-Factor Prothrombin Complex Concentrates (PCC), Activated 4-Factor Prothrombin Complex Concentrates (PCC)

3) By Type: Recombinant Coagulation Factor Complexes, Plasma-Derived Coagulation Factor Complexes, Combination Therapy Products

What Is Driving The Prothrombin Complex Concentrate Market? Rising Prevalence Of Bleeding Disorders Driving The Growth Of The Market Due To Increasing Genetic Mutations and Inherited Conditions

The increasing prevalence of bleeding disorders is expected to propel the growth of the prothrombin complex concentrate market going forward. Bleeding disorders are medical conditions where the blood does not clot properly, leading to excessive bleeding due to missing or malfunctioning clotting factors or platelets. Bleeding disorders are increasing mainly due to the rising prevalence of genetic conditions such as hemophilia, increasing cases of liver disease, the growing use of anticoagulant medications, and a higher incidence of vitamin K deficiencies. Prothrombin complex concentrate helps treat bleeding disorders by rapidly replenishing clotting factors, which are essential for effective blood coagulation and hemostasis. For instance, in November 2023, the National Library of Medicine, a U.S.-based medical library, reported that in 2022, a study involving 10,276 individuals with hemophilia was conducted across 87 treatment centers in 40 countries. Nearly 49% of the participants had severe hemophilia, 99% were male, and 85% were diagnosed with hemophilia A. Moreover, 67% of the patients were from low- and middle-income countries. Therefore, the increasing prevalence of bleeding disorders is driving the growth of the prothrombin complex concentrate industry.

What Is Driving The Prothrombin Complex Concentrate Market? Growing Prescription Rate Of Anticoagulants Fueling The Market Due To Rising Prevalence Of Cardiovascular Diseases

The growing prescription rate of anticoagulants is expected to propel the growth of the prothrombin complex concentrate market going forward. An anticoagulant is a substance that prevents or reduces blood clot formation by inhibiting coagulation factors or platelet aggregation. The growing prescription rate of anticoagulants is due to the rising prevalence of cardiovascular diseases, an aging population, expanding clinical indications, improved screening programs, and advancements in anticoagulant therapy. Prothrombin complex concentrate counteracts the effects of anticoagulants by rapidly replenishing clotting factors and restoring hemostasis in patients with excessive bleeding or urgent surgical needs. For instance, in November 2023, according to the National Health Service, a UK-based government department, in 2022, 460,000 more people began taking anticoagulant medications, with over 24 million prescriptions issued to patients, helping to prevent an estimated 17,000 strokes and 4,000 deaths. Therefore, the growing prescription rate of anticoagulants is driving the growth of the prothrombin complex concentrate industry.

Who Are The Major Players In The Global Prothrombin Complex Concentrate Market?

Major companies operating in the prothrombin complex concentrate market are Pfizer Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, CSL Behring GmbH, Intas Pharmaceuticals Ltd, Baxter International Inc, Grifols S.A., Octapharma AG, Kedrion S.p.A, Haemonetics Corporation, Green Cross Corporation, Shanghai RAAS Blood Products Co. Ltd, Emergent BioSolutions, LFB Group, Hualan Biological Engineering Chongqing Co. Ltd., Sanquin Blood Supply Foundation, Bio Products Laboratory Ltd (BPL), Prothya Biosolutions B.V., China Biologic Products Holdings Inc.

What Are The Key Trends Of The Global Prothrombin Complex Concentrate Market? Development Of Innovative Formulations In The Market

Major companies operating in the prothrombin complex concentrate market are developing innovative formulations such as lyophilized powder to enhance stability, improve storage, and simplify administration. The lyophilized powder is a freeze-dried formulation that removes water to increase shelf life and maintain potency. This allows for better storage conditions and rapid reconstitution for emergency use. For instance, in July 2023, Octapharma USA Inc., a US-based biotechnology company, received FDA approval for Balfaxar, a four-factor prothrombin complex concentrate (4F-PCC) for urgent warfarin reversal in surgeries and invasive procedures. The approval was based on the LEX-209 trial, which showed 94.6% hemostatic efficacy, proving it as effective as Kcentra. This advancement underscores the industry's focus on improving coagulation therapies to enhance patient outcomes in critical care settings.

Need data on a specific region in this market?

What Is The Regional Outlook For The Global Prothrombin Complex Concentrate Market?

North America was the largest region in the prothrombin complex concentrate market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prothrombin Complex Concentrate Market?

The prothrombin complex concentrate market consists of sales of activated PCC, recombinant coagulation factors, combination hemostatic agents, warfarin reversal, and emergency coagulation therapy products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Prothrombin Complex Concentrate Industry?

The prothrombin complex concentrate market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prothrombin complex concentrate industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Prothrombin Complex Concentrate Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.38 billion
Revenue Forecast In 2034 $1.83 billion
Growth Rate CAGR of 7.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The prothrombin complex concentrate market covered in this report is segmented –
1) By Product: 3-Factor Prothrombin Complex Concentrates, 4-Factor Prothrombin Complex Concentrates, Other Products
2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B), Trauma, Life-Threatening Coagulopathy With Acute Bleeding, Warfarin-Associated Acute, Life-Threatening Bleeding, Non-Warfarin Anticoagulant Reversal With Acute Bleeding
3) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular
4) By End-Use: Hospital And Ambulatory Surgical Centers, Specialty Clinics, Other End Users Subsegments:
1) By Type: Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC), High-Dose 3-Factor Prothrombin Complex Concentrates (PCC), Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)
2) By Type: Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC), High-Dose 4-Factor Prothrombin Complex Concentrates (PCC), Activated 4-Factor Prothrombin Complex Concentrates (PCC)
3) By Type: Recombinant Coagulation Factor Complexes, Plasma-Derived Coagulation Factor Complexes, Combination Therapy Products
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Request for Sample
Customization ScopeExplore Purchase Options
Pricing And Purchase Options

Table Of Contents

1. Executive Summary

2. Prothrombin Complex Concentrate Market Characteristics

3. Prothrombin Complex Concentrate Market Trends And Strategies

4. Prothrombin Complex Concentrate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prothrombin Complex Concentrate Growth Analysis And Strategic Analysis Framework

5.1. Global Prothrombin Complex Concentrate PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Prothrombin Complex Concentrate Market Growth Rate Analysis

5.4. Global Prothrombin Complex Concentrate Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Prothrombin Complex Concentrate Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Prothrombin Complex Concentrate Total Addressable Market (TAM)

6. Prothrombin Complex Concentrate Market Segmentation

6.1. Global Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

3-Factor Prothrombin Complex Concentrates

4-Factor Prothrombin Complex Concentrates

Other Products

6.2. Global Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B)

Trauma

Life-Threatening Coagulopathy With Acute Bleeding

Warfarin-Associated Acute, Life-Threatening Bleeding

Non-Warfarin Anticoagulant Reversal With Acute Bleeding

6.3. Global Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous

Subcutaneous

Intramuscular

6.4. Global Prothrombin Complex Concentrate Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital And Ambulatory Surgical Centers

Specialty Clinics

Other End Users

6.5. Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 3-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC)

High-Dose 3-Factor Prothrombin Complex Concentrates (PCC)

Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)

6.6. Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 4-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC)

High-Dose 4-Factor Prothrombin Complex Concentrates (PCC)

Activated 4-Factor Prothrombin Complex Concentrates (PCC)

6.7. Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Coagulation Factor Complexes

Plasma-Derived Coagulation Factor Complexes

Combination Therapy Products

7. Prothrombin Complex Concentrate Market Regional And Country Analysis

7.1. Global Prothrombin Complex Concentrate Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Prothrombin Complex Concentrate Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prothrombin Complex Concentrate Market

8.1. Asia-Pacific Prothrombin Complex Concentrate Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prothrombin Complex Concentrate Market

9.1. China Prothrombin Complex Concentrate Market Overview

9.2. China Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prothrombin Complex Concentrate Market

10.1. India Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prothrombin Complex Concentrate Market

11.1. Japan Prothrombin Complex Concentrate Market Overview

11.2. Japan Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prothrombin Complex Concentrate Market

12.1. Australia Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prothrombin Complex Concentrate Market

13.1. Indonesia Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prothrombin Complex Concentrate Market

14.1. South Korea Prothrombin Complex Concentrate Market Overview

14.2. South Korea Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prothrombin Complex Concentrate Market

15.1. Western Europe Prothrombin Complex Concentrate Market Overview

15.2. Western Europe Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prothrombin Complex Concentrate Market

16.1. UK Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prothrombin Complex Concentrate Market

17.1. Germany Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prothrombin Complex Concentrate Market

18.1. France Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prothrombin Complex Concentrate Market

19.1. Italy Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prothrombin Complex Concentrate Market

20.1. Spain Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prothrombin Complex Concentrate Market

21.1. Eastern Europe Prothrombin Complex Concentrate Market Overview

21.2. Eastern Europe Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prothrombin Complex Concentrate Market

22.1. Russia Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prothrombin Complex Concentrate Market

23.1. North America Prothrombin Complex Concentrate Market Overview

23.2. North America Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prothrombin Complex Concentrate Market

24.1. USA Prothrombin Complex Concentrate Market Overview

24.2. USA Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prothrombin Complex Concentrate Market

25.1. Canada Prothrombin Complex Concentrate Market Overview

25.2. Canada Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prothrombin Complex Concentrate Market

26.1. South America Prothrombin Complex Concentrate Market Overview

26.2. South America Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prothrombin Complex Concentrate Market

27.1. Brazil Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prothrombin Complex Concentrate Market

28.1. Middle East Prothrombin Complex Concentrate Market Overview

28.2. Middle East Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prothrombin Complex Concentrate Market

29.1. Africa Prothrombin Complex Concentrate Market Overview

29.2. Africa Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prothrombin Complex Concentrate Market Competitive Landscape And Company Profiles

30.1. Prothrombin Complex Concentrate Market Competitive Landscape

30.2. Prothrombin Complex Concentrate Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

30.2.5. CSL Behring GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Prothrombin Complex Concentrate Market Other Major And Innovative Companies

31.1. Intas Pharmaceuticals Ltd

31.2. Baxter International Inc

31.3. Grifols S.A.

31.4. Octapharma AG

31.5. Kedrion S.p.A

31.6. Haemonetics Corporation

31.7. Green Cross Corporation

31.8. Shanghai RAAS Blood Products Co. Ltd

31.9. Emergent BioSolutions

31.10. LFB Group

31.11. Hualan Biological Engineering Chongqing Co. Ltd.

31.12. Sanquin Blood Supply Foundation

31.13. Bio Products Laboratory Ltd (BPL)

31.14. Prothya Biosolutions B.V.

31.15. China Biologic Products Holdings Inc

32. Global Prothrombin Complex Concentrate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prothrombin Complex Concentrate Market

34. Recent Developments In The Prothrombin Complex Concentrate Market

35. Prothrombin Complex Concentrate Market High Potential Countries, Segments and Strategies

35.1 Prothrombin Complex Concentrate Market In 2029 - Countries Offering Most New Opportunities

35.2 Prothrombin Complex Concentrate Market In 2029 - Segments Offering Most New Opportunities

35.3 Prothrombin Complex Concentrate Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Prothrombin Complex Concentrate Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 3-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 4-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Prothrombin Complex Concentrate Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Prothrombin Complex Concentrate Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Bristol-Myers Squibb Company Financial Performance
  • Table 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 81: Novo Nordisk A/S Financial Performance
  • Table 82: CSL Behring GmbH Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Prothrombin Complex Concentrate Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 3-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of 4-Factor Prothrombin Complex Concentrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Prothrombin Complex Concentrate Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Prothrombin Complex Concentrate Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Prothrombin Complex Concentrate Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Prothrombin Complex Concentrate Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Prothrombin Complex Concentrate Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Prothrombin Complex Concentrate Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Bristol-Myers Squibb Company Financial Performance
  • Figure 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 81: Novo Nordisk A/S Financial Performance
  • Figure 82: CSL Behring GmbH Financial Performance

Frequently Asked Questions

Prothrombin complex concentrate (PCC) is a medication containing clotting factors used to treat or prevent bleeding in patients with coagulation disorders. It is administered intravenously to rapidly restore clotting factor levels in conditions such as hemophilia, warfarin reversal, and severe bleeding episodes. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Bleeding Disorders Driving The Growth Of The Market Due To Increasing Genetic Mutations and Inherited Conditions. For further insights on this market, request a sample here

The prothrombin complex concentrate market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in the prevalence of bleeding disorders, increased use in warfarin reversal, growth in awareness of coagulation therapies, expansion of surgical procedures, and increased trauma cases. The prothrombin complex concentrate market size is expected to see strong growth in the next few years. It will grow to " $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growing demand for rapid coagulation therapies, increasing prevalence of hemophilia and liver diseases, rising adoption in emergency medicine, expanding applications in cardiac surgeries, and increasing healthcare expenditure. Major trends in the forecast period include integration of AI-driven diagnostics, advancements in recombinant coagulation factors, next-generation recombinant pccs, customized dosing algorithms and advancements in blood plasma products. For further insights on this market, request a sample here

The prothrombin complex concentratemarket covered in this report is segmented –
1) By Product: 3-Factor Prothrombin Complex Concentrates; 4-Factor Prothrombin Complex Concentrates; Other Products
2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B); Trauma; Life-Threatening Coagulopathy With Acute Bleeding; Warfarin-Associated Acute, Life-Threatening Bleeding; Non-Warfarin Anticoagulant Reversal With Acute Bleeding
3) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular
4) By End-Use: Hospital And Ambulatory Surgical Centers; Specialty Clinics; Other End Users Subsegments:
1) By Type: Low-Dose 3-Factor Prothrombin Complex Concentrates (PCC); High-Dose 3-Factor Prothrombin Complex Concentrates (PCC); Lyophilized 3-Factor Prothrombin Complex Concentrates (PCC)
2) By Type: Low-Dose 4-Factor Prothrombin Complex Concentrates (PCC); High-Dose 4-Factor Prothrombin Complex Concentrates (PCC); Activated 4-Factor Prothrombin Complex Concentrates (PCC)
3) By Type: Recombinant Coagulation Factor Complexes; Plasma-Derived Coagulation Factor Complexes; Combination Therapy Products For further insights on this market,
request a sample here

North America was the largest region in the prothrombin complex concentrate market in 2024. The regions covered in the prothrombin complex concentrate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the prothrombin complex concentrate market are Pfizer Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, CSL Behring GmbH, Intas Pharmaceuticals Ltd, Baxter International Inc, Grifols S.A., Octapharma AG, Kedrion S.p.A, Haemonetics Corporation, Green Cross Corporation, Shanghai RAAS Blood Products Co. Ltd, Emergent BioSolutions, LFB Group, Hualan Biological Engineering Chongqing Co. Ltd., Sanquin Blood Supply Foundation, Bio Products Laboratory Ltd (BPL), Prothya Biosolutions B.V., China Biologic Products Holdings Inc. . For further insights on this market, request a sample here.

Major trends in this market include Development Of Innovative Formulations In The Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon